Hoberman Kenneth (CIK 0001573722)

Latest company ownership

Shares held
133,140
Last filed at
Jun 12, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 12, 2022 May 16, 2022 Nuvectis Pharma, Inc. Director Buy 95.0 +6,000 12.21% $104.4K